Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection
Clinical trial NCT06784973 · TERMINATED
Trial details
- NCT number
- NCT06784973
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2025-04-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.